{"id":49736,"date":"2022-10-18T13:01:57","date_gmt":"2022-10-18T11:01:57","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/biointellisense-acquires-alertwatch-clinical-intelligence-engine-to-expand-its-comprehensive-portfolio-of-continuous-patient-monitoring-solutions\/"},"modified":"2022-10-18T13:01:57","modified_gmt":"2022-10-18T11:01:57","slug":"biointellisense-acquires-alertwatch-clinical-intelligence-engine-to-expand-its-comprehensive-portfolio-of-continuous-patient-monitoring-solutions","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/biointellisense-acquires-alertwatch-clinical-intelligence-engine-to-expand-its-comprehensive-portfolio-of-continuous-patient-monitoring-solutions\/","title":{"rendered":"BioIntelliSense Acquires AlertWatch\u00ae Clinical Intelligence Engine to Expand its Comprehensive Portfolio of Continuous Patient Monitoring Solutions"},"content":{"rendered":"<div>\n<ul class=\"bwlistdisc\">\n<li>\n<i>The FDA-cleared AlertWatch<sup>\u00ae<\/sup> clinical intelligence and triage system spans healthcare settings and seamlessly integrates with BioIntelliSense\u2019s medical-grade BioButton<sup>\u00ae<\/sup> wearables for scalable in-hospital patient monitoring and at-home remote care<\/i>\n<\/li>\n<\/ul>\n<ul class=\"bwlistdisc\">\n<li>\n<i>Medtronic Patient Monitoring business to offer AlertWatch solution to U.S. Hospitals<\/i>\n<\/li>\n<\/ul>\n<p>DENVER&#8211;(BUSINESS WIRE)&#8211;<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.biointellisense.com%2F&amp;esheet=52946874&amp;newsitemid=20221018005525&amp;lan=en-US&amp;anchor=BioIntelliSense%2C+Inc.&amp;index=1&amp;md5=d25e194e23cb2259942fc29fe91f2385\" rel=\"nofollow noopener\" shape=\"rect\">BioIntelliSense, Inc.<\/a>, a continuous health monitoring and clinical intelligence company, today announced its acquisition of <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.alertwatch.com%2F&amp;esheet=52946874&amp;newsitemid=20221018005525&amp;lan=en-US&amp;anchor=AlertWatch&amp;index=2&amp;md5=42de4de8739727588c90e051f44e1d51\" rel=\"nofollow noopener\" shape=\"rect\">AlertWatch<\/a><i><sup>\u00ae<\/sup><\/i>, an FDA-cleared, clinically proven patient monitoring solution. AlertWatch uniquely provides robust integration, data analysis and a patented intuitive display of contextual patient data for more efficient, actionable clinical decisions. As part of the recently announced strategic partnership with Medtronic, its Patient Monitoring business will distribute AlertWatch to hospitals throughout the U.S. as a new offering in its HealthCast\u2122 portfolio.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20221018005525\/en\/1605175\/5\/BioIntelliSense_Logo_Black.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20221018005525\/en\/1605175\/21\/BioIntelliSense_Logo_Black.jpg\"><\/a><\/p>\n<p>\n\u201cThe addition of AlertWatch offers healthcare providers comprehensive continuous monitoring solutions, and an accelerated path from adoption to full scale utilization,\u201d said James Mault, MD, founder and CEO of BioIntelliSense. \u201cThe patented AlertWatch multi-parameter interface displays and analyzes data from inpatient vitals, the electronic medical record (EMR), laboratory systems and BioIntelliSense medical-grade wearables, to provide clinical intelligence across care settings and acuity levels.\u201d\n<\/p>\n<p>\nHospitals nationwide are seeking enterprise-grade platforms that optimize labor intensive processes through automation of data capture combined with scalable exception management and clinical insights from in-hospital to home. Over the past decade, AlertWatch has earned four FDA 510(k) clearances for its specialized product offerings for the operating room, intensive care unit, and labor and delivery unit. AlertWatch is also monitoring patients in general care wards\u2013and now, in the home.\n<\/p>\n<p>\nThe AlertWatch centralized triage dashboard aggregates data and provides clinicians with a composite view of patient vital sign trends, while simultaneously performing advanced analytics and alerting, for proactive clinical decisions. The AlertWatch system has been used to assist over one million surgeries and over 25,000 births. The AlertWatch operating room solution, when comparing users versus non-users, was associated with a one-day reduction in post-operative length of stay (LOS) and a $3,603 reduction in encounter charges.<sup>1<\/sup>\n<\/p>\n<p>\n\u201cBy joining forces with BioIntelliSense, we are thrilled to greatly expand the reach and adoption of our world-class clinical decision support solution,\u201d said Professor Kevin Tremper, MD, PhD, founder and President of AlertWatch. \u201cThe workflow automation benefits not only help to reduce hospital stays and costs, but also assist clinicians and nurses by alerting them with highly actionable information that prioritizes and personalizes patient care.\u201d\n<\/p>\n<p>\nThe BioIntelliSense and AlertWatch platforms are interoperable solutions with extensive third party and EMR system integration and data exchange capabilities. BioIntelliSense remains committed to an ecosystem approach that provides the flexibility, security and scalability that is needed to support our customers\u2019 patient monitoring needs.\n<\/p>\n<p>\n\u201dI am excited to see our partnership with BioIntelliSense expand so, together, we can help more patients in more places,\u201d said Frank Chan, president of the Patient Monitoring business, which is part of the Medical Surgical Portfolio at Medtronic. \u201cThe addition of the AlertWatch system to our HealthCast\u2122 portfolio of connectivity and remote monitoring solutions strengthens our commitment to patient safety and enables workflow efficiency for our customers as they monitor patients in-hospital and at-home.\u201d\n<\/p>\n<p>\nAlertWatch (Booth # 2909) and Medtronic (Booth # 3228) will be demonstrating the BioIntelliSense BioButton and AlertWatch solutions at the American Society of Anesthesiologists (ASA) <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.asahq.org%2Fannualmeeting&amp;esheet=52946874&amp;newsitemid=20221018005525&amp;lan=en-US&amp;anchor=ANESTHESIOLOGY+2022&amp;index=3&amp;md5=0cdd4db6e94fe2d751f6b29bfca1f474\" rel=\"nofollow noopener\" shape=\"rect\">ANESTHESIOLOGY 2022<\/a> annual meeting.\n<\/p>\n<p>\nFor the latest news and information on how BioIntelliSense is making early detection simple\u2122 through medical-grade wearable technology and cost-effective data services, visit our website at <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.biointellisense.com%2F&amp;esheet=52946874&amp;newsitemid=20221018005525&amp;lan=en-US&amp;anchor=biointellisense.com&amp;index=4&amp;md5=ffdc14ad197040c3c13feca23eff22e7\" rel=\"nofollow noopener\" shape=\"rect\">biointellisense.com<\/a> and follow BioIntelliSense on <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Ftwitter.com%2Fbiointellisense&amp;esheet=52946874&amp;newsitemid=20221018005525&amp;lan=en-US&amp;anchor=Twitter&amp;index=5&amp;md5=f173932d52f731569a3020f145884002\" rel=\"nofollow noopener\" shape=\"rect\">Twitter<\/a> and <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fbiointellisense%2F&amp;esheet=52946874&amp;newsitemid=20221018005525&amp;lan=en-US&amp;anchor=LinkedIn&amp;index=6&amp;md5=957c01a017df275bda6e5020e3117b15\" rel=\"nofollow noopener\" shape=\"rect\">LinkedIn<\/a>.\n<\/p>\n<p>\n<b>Reference:<\/b>\n<\/p>\n<p>\n1. Kheterpal S, Shanks A, Tremper KK. Impact of a novel multiparameter decision support system on intraoperative processes of care and postoperative outcomes. <i>Anesthesiology<\/i>. 2018;128(2):272-282.\n<\/p>\n<p>\n<b>ABOUT BIOINTELLISENSE<br \/>\n<br \/><\/b>BioIntelliSense is ushering in a new era of continuous health monitoring and clinical intelligence for remote patient monitoring (RPM). Its medical-grade Data-as-a-Service (DaaS) platform seamlessly captures multi-parameter vital signs, physiological biometrics and symptomatic events through an effortless patient experience. The medical-grade BioButton<sup>\u00ae<\/sup> wearable device makes remote monitoring and early detection simple. Through the platform\u2019s advanced analytics, clinicians have access to high-resolution patient trending and reporting to enable medical grade remote care from in-hospital to home.\n<\/p>\n<p>\nLearn how BioIntelliSense is redefining remote patient monitoring through medical-grade and cost-effective data services by visiting our website at <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.biointellisense.com%2F&amp;esheet=52946874&amp;newsitemid=20221018005525&amp;lan=en-US&amp;anchor=biointellisense.com&amp;index=7&amp;md5=ff988ae2005b46c141bac073bc407468\" rel=\"nofollow noopener\" shape=\"rect\">biointellisense.com<\/a>. Follow BioIntelliSense on <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Ftwitter.com%2Fbiointellisense&amp;esheet=52946874&amp;newsitemid=20221018005525&amp;lan=en-US&amp;anchor=Twitter&amp;index=8&amp;md5=d3ffd1ea7905632e082331ef531d925e\" rel=\"nofollow noopener\" shape=\"rect\">Twitter<\/a> and <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fbiointellisense%2F&amp;esheet=52946874&amp;newsitemid=20221018005525&amp;lan=en-US&amp;anchor=LinkedIn&amp;index=9&amp;md5=708258467b01aa0fe64b71800f34529b\" rel=\"nofollow noopener\" shape=\"rect\">LinkedIn<\/a> for the latest news and information.\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\n<b>Media Contact:<\/b><br \/>Eric Schudiske<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#x61;&#x69;&#x6c;&#x74;&#x6f;&#x3a;&#x65;&#114;&#105;&#99;&#64;&#115;&#50;&#115;pr&#46;c&#x6f;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">&#x65;&#114;i&#x63;&#64;s&#x32;&#115;p&#x72;&#x2e;&#99;&#x6f;&#x6d;<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>The FDA-cleared AlertWatch\u00ae clinical intelligence and triage system spans healthcare settings and seamlessly integrates with BioIntelliSense\u2019s medical-grade BioButton\u00ae wearables for scalable in-hospital patient monitoring and at-home remote care Medtronic Patient Monitoring business to offer AlertWatch solution to U.S. Hospitals DENVER&#8211;(BUSINESS WIRE)&#8211;BioIntelliSense, Inc., a continuous health monitoring and clinical intelligence company, today announced its acquisition of &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/biointellisense-acquires-alertwatch-clinical-intelligence-engine-to-expand-its-comprehensive-portfolio-of-continuous-patient-monitoring-solutions\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-49736","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>BioIntelliSense Acquires AlertWatch\u00ae Clinical Intelligence Engine to Expand its Comprehensive Portfolio of Continuous Patient Monitoring Solutions - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/biointellisense-acquires-alertwatch-clinical-intelligence-engine-to-expand-its-comprehensive-portfolio-of-continuous-patient-monitoring-solutions\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BioIntelliSense Acquires AlertWatch\u00ae Clinical Intelligence Engine to Expand its Comprehensive Portfolio of Continuous Patient Monitoring Solutions - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"The FDA-cleared AlertWatch\u00ae clinical intelligence and triage system spans healthcare settings and seamlessly integrates with BioIntelliSense\u2019s medical-grade BioButton\u00ae wearables for scalable in-hospital patient monitoring and at-home remote care Medtronic Patient Monitoring business to offer AlertWatch solution to U.S. Hospitals DENVER&#8211;(BUSINESS WIRE)&#8211;BioIntelliSense, Inc., a continuous health monitoring and clinical intelligence company, today announced its acquisition of ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/biointellisense-acquires-alertwatch-clinical-intelligence-engine-to-expand-its-comprehensive-portfolio-of-continuous-patient-monitoring-solutions\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-18T11:01:57+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221018005525\/en\/1605175\/21\/BioIntelliSense_Logo_Black.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/biointellisense-acquires-alertwatch-clinical-intelligence-engine-to-expand-its-comprehensive-portfolio-of-continuous-patient-monitoring-solutions\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/biointellisense-acquires-alertwatch-clinical-intelligence-engine-to-expand-its-comprehensive-portfolio-of-continuous-patient-monitoring-solutions\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"BioIntelliSense Acquires AlertWatch\u00ae Clinical Intelligence Engine to Expand its Comprehensive Portfolio of Continuous Patient Monitoring Solutions\",\"datePublished\":\"2022-10-18T11:01:57+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/biointellisense-acquires-alertwatch-clinical-intelligence-engine-to-expand-its-comprehensive-portfolio-of-continuous-patient-monitoring-solutions\\\/\"},\"wordCount\":730,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/biointellisense-acquires-alertwatch-clinical-intelligence-engine-to-expand-its-comprehensive-portfolio-of-continuous-patient-monitoring-solutions\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221018005525\\\/en\\\/1605175\\\/21\\\/BioIntelliSense_Logo_Black.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/biointellisense-acquires-alertwatch-clinical-intelligence-engine-to-expand-its-comprehensive-portfolio-of-continuous-patient-monitoring-solutions\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/biointellisense-acquires-alertwatch-clinical-intelligence-engine-to-expand-its-comprehensive-portfolio-of-continuous-patient-monitoring-solutions\\\/\",\"name\":\"BioIntelliSense Acquires AlertWatch\u00ae Clinical Intelligence Engine to Expand its Comprehensive Portfolio of Continuous Patient Monitoring Solutions - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/biointellisense-acquires-alertwatch-clinical-intelligence-engine-to-expand-its-comprehensive-portfolio-of-continuous-patient-monitoring-solutions\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/biointellisense-acquires-alertwatch-clinical-intelligence-engine-to-expand-its-comprehensive-portfolio-of-continuous-patient-monitoring-solutions\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221018005525\\\/en\\\/1605175\\\/21\\\/BioIntelliSense_Logo_Black.jpg\",\"datePublished\":\"2022-10-18T11:01:57+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/biointellisense-acquires-alertwatch-clinical-intelligence-engine-to-expand-its-comprehensive-portfolio-of-continuous-patient-monitoring-solutions\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/biointellisense-acquires-alertwatch-clinical-intelligence-engine-to-expand-its-comprehensive-portfolio-of-continuous-patient-monitoring-solutions\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/biointellisense-acquires-alertwatch-clinical-intelligence-engine-to-expand-its-comprehensive-portfolio-of-continuous-patient-monitoring-solutions\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221018005525\\\/en\\\/1605175\\\/21\\\/BioIntelliSense_Logo_Black.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221018005525\\\/en\\\/1605175\\\/21\\\/BioIntelliSense_Logo_Black.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/biointellisense-acquires-alertwatch-clinical-intelligence-engine-to-expand-its-comprehensive-portfolio-of-continuous-patient-monitoring-solutions\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BioIntelliSense Acquires AlertWatch\u00ae Clinical Intelligence Engine to Expand its Comprehensive Portfolio of Continuous Patient Monitoring Solutions\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"BioIntelliSense Acquires AlertWatch\u00ae Clinical Intelligence Engine to Expand its Comprehensive Portfolio of Continuous Patient Monitoring Solutions - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/biointellisense-acquires-alertwatch-clinical-intelligence-engine-to-expand-its-comprehensive-portfolio-of-continuous-patient-monitoring-solutions\/","og_locale":"en_US","og_type":"article","og_title":"BioIntelliSense Acquires AlertWatch\u00ae Clinical Intelligence Engine to Expand its Comprehensive Portfolio of Continuous Patient Monitoring Solutions - Pharma Trend","og_description":"The FDA-cleared AlertWatch\u00ae clinical intelligence and triage system spans healthcare settings and seamlessly integrates with BioIntelliSense\u2019s medical-grade BioButton\u00ae wearables for scalable in-hospital patient monitoring and at-home remote care Medtronic Patient Monitoring business to offer AlertWatch solution to U.S. Hospitals DENVER&#8211;(BUSINESS WIRE)&#8211;BioIntelliSense, Inc., a continuous health monitoring and clinical intelligence company, today announced its acquisition of ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/biointellisense-acquires-alertwatch-clinical-intelligence-engine-to-expand-its-comprehensive-portfolio-of-continuous-patient-monitoring-solutions\/","og_site_name":"Pharma Trend","article_published_time":"2022-10-18T11:01:57+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221018005525\/en\/1605175\/21\/BioIntelliSense_Logo_Black.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/biointellisense-acquires-alertwatch-clinical-intelligence-engine-to-expand-its-comprehensive-portfolio-of-continuous-patient-monitoring-solutions\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/biointellisense-acquires-alertwatch-clinical-intelligence-engine-to-expand-its-comprehensive-portfolio-of-continuous-patient-monitoring-solutions\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"BioIntelliSense Acquires AlertWatch\u00ae Clinical Intelligence Engine to Expand its Comprehensive Portfolio of Continuous Patient Monitoring Solutions","datePublished":"2022-10-18T11:01:57+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/biointellisense-acquires-alertwatch-clinical-intelligence-engine-to-expand-its-comprehensive-portfolio-of-continuous-patient-monitoring-solutions\/"},"wordCount":730,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/biointellisense-acquires-alertwatch-clinical-intelligence-engine-to-expand-its-comprehensive-portfolio-of-continuous-patient-monitoring-solutions\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221018005525\/en\/1605175\/21\/BioIntelliSense_Logo_Black.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/biointellisense-acquires-alertwatch-clinical-intelligence-engine-to-expand-its-comprehensive-portfolio-of-continuous-patient-monitoring-solutions\/","url":"https:\/\/pharma-trend.com\/en\/biointellisense-acquires-alertwatch-clinical-intelligence-engine-to-expand-its-comprehensive-portfolio-of-continuous-patient-monitoring-solutions\/","name":"BioIntelliSense Acquires AlertWatch\u00ae Clinical Intelligence Engine to Expand its Comprehensive Portfolio of Continuous Patient Monitoring Solutions - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/biointellisense-acquires-alertwatch-clinical-intelligence-engine-to-expand-its-comprehensive-portfolio-of-continuous-patient-monitoring-solutions\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/biointellisense-acquires-alertwatch-clinical-intelligence-engine-to-expand-its-comprehensive-portfolio-of-continuous-patient-monitoring-solutions\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221018005525\/en\/1605175\/21\/BioIntelliSense_Logo_Black.jpg","datePublished":"2022-10-18T11:01:57+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/biointellisense-acquires-alertwatch-clinical-intelligence-engine-to-expand-its-comprehensive-portfolio-of-continuous-patient-monitoring-solutions\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/biointellisense-acquires-alertwatch-clinical-intelligence-engine-to-expand-its-comprehensive-portfolio-of-continuous-patient-monitoring-solutions\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/biointellisense-acquires-alertwatch-clinical-intelligence-engine-to-expand-its-comprehensive-portfolio-of-continuous-patient-monitoring-solutions\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221018005525\/en\/1605175\/21\/BioIntelliSense_Logo_Black.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221018005525\/en\/1605175\/21\/BioIntelliSense_Logo_Black.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/biointellisense-acquires-alertwatch-clinical-intelligence-engine-to-expand-its-comprehensive-portfolio-of-continuous-patient-monitoring-solutions\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"BioIntelliSense Acquires AlertWatch\u00ae Clinical Intelligence Engine to Expand its Comprehensive Portfolio of Continuous Patient Monitoring Solutions"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49736","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=49736"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49736\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=49736"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=49736"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=49736"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}